A Phase 1 Study of Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian Cancer
Phase of Trial: Phase I
Latest Information Update: 04 Aug 2016
At a glance
- Drugs Veliparib (Primary) ; Carboplatin; Paclitaxel
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions
- Sponsors AbbVie
- 01 Aug 2016 Status changed from active, no longer recruiting to completed.
- 13 Mar 2016 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
- 08 Feb 2016 Planned End Date changed from 1 Jun 2016 to 1 Aug 2016, according to ClinicalTrials.gov record.